Tamoxifen treatment of KT;Lkb1XTR/XTR mice (which lack FLPo-ERT2) had no impact on tumor burden (Fig. 1c–e and Supplementary Fig. 3a, b). The gene discussed is MAPK3; the disease is neoplasm.